• About Us
  • Success Stories
  • Articles
  • FAQ
  • Contact Us
Accell Clinical Research
  • Our Services
    • Clinical Trial Management
    • Functional Outsourcing
    • Strategic Guidance & Trial Set-up
  • Our Locations
  • Rescue Studies
  • Accell Oncology
Select Page

CPHIFrnkfurt2022_840x500

by bd@accellclinical.com | Oct 3, 2022 | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Comments

    Archives

    Categories

    • No categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Company News

    November 10, 2023

    Accell at Medidata NEXT New York 2023: Mapping the Future of Clinical Research

    Accell’s team recently attended an industry-leading event, Medidata NEXT New York 2023 conference, held on November 7-8 in the heart of Midtown Manhattan.

    April 3, 2023

    Accell has launched new challenging projects

    Accell’s team is enthusiastic to announce that it is about to start two new Phase III studies in oncology and ophthalmology.

    Events

    CPHI Frankfurt 2022

    Meet Accell’s team at the biggest pharma industry event of 2022 – CPHI Frankfurt, held at Messe Frankfurt, Frankfurt, Germany on November 1-3, 2022.

    2022 ASCO Annual Meeting

    Learn numerous advantages of running an oncology clinical trial in Eastern Europe from Accell’s team, your trusted CRO partner.

    Immuno-Oncology 360°

    On February 26-28, 2020 Natalia Nayanova, Accell’s Founder and Managing Member, attended the annual conference “Immuno-Oncology 360°” held in Crowne Plaza Times Square in New York City.

    Accell Clinical Research, LLC is an International Contract Research Organization (CRO) supporting innovation with superior clinical trial services in Europe and the Eurasian Economic Union for over a decade.
    • Facebook
    • 
    • Careers
    • Privacy Notice
    • Site Map
    X

    We are here when you need us.
    Get in touch and let’s start something great together.

      Sign Up for Accell’s Newsletter